Health
SARS-CoV-2 replicon for high-throughput antiviral screening – DocWire News
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001583.ABSTRACTThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly
J Gen Virol. 2021 May;102(5). doi: 10.1099/jgv.0.001583.
ABSTRACT
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly pathogenic and classified as a biosafety level 3 (BSL-3) agent, has greatly threatened global health and efficacious antivirals are urgently needed. The high requirement of facilities to manipulate the live virus has limited the development of antiviral study. Here, we constructed a reporter replicon of SARS-CoV-2, which can be handled in a BSL-2…
-
General20 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General21 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News17 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
Business24 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years